T1	Participants 56 92	AJCC/UICC stage II colorectal cancer
T2	Participants 357 473	patients with American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) stage II disease
T3	Participants 483 585	Tumors of 120 randomly selected patients with AJCC/UICC stage II disease were retrospectively reviewed
